Weight gain and lipid-glucose profiles among patients taking antipsychotic medications: Comparisons for prescriptions administered using algorithms versus usual care

Journal of Psychiatric and Mental Health Nursing

Volumn 19, Issue 5, 2012, Pages 389-394

  Koch, D A ^a   Scott, A J ^b  

^a UNIVERSITY OF ARKANSAS FORT SMITH   (United States)

^b UNIVERSITY OF ARKANSAS   (United States)

Author keywords

Algorithm; Antipsychotic; Criteria; Evidence based practice; Metabolic; Prescribing

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AGED; ALGORITHM; ARTICLE; CHEMICALLY INDUCED DISORDER; CLINICAL PRACTICE; COMPARATIVE STUDY; EVIDENCE BASED PRACTICE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; STATISTICAL MODEL; UNITED STATES; WEIGHT GAIN;

ADULT; AGED; ALGORITHMS; ANTIPSYCHOTIC AGENTS; DIABETES MELLITUS, TYPE 2; EVIDENCE-BASED PRACTICE; FEMALE; GUIDELINE ADHERENCE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES; TEXAS; WEIGHT GAIN;

EID: 84860432003     PISSN: 13510126     EISSN: 13652850     Source Type: Journal    
DOI: 10.1111/j.1365-2850.2011.01781.x     Document Type: Article

References (12)

1. Baker R.A., Pikalov A., Van Tran Q., etal. (2009) Atypical antipsychotic drugs and diabetes mellitus in the US food and drug administration adverse event database: a systematic Bayesian signal detection. Available at: (accessed 2 February 2009).
2. Busko M. (2007) Monitoring of metabolic adverse effects from antipsychotics could be improved. Available at: (accessed 18 January 2009).
3. Gibson A.P., Patel N.C., Lauriello J., etal. (2008) Antipsychotic combinations: blind step or logical. Current Psychiatry 7, 40-53.
4. Jennex A. & Gardner D.M. (2008) Monitoring and management of metabolic risk factors in outpatients taking antipsychotic drugs: a controlled study. Available at: (accessed 28 January 2008).
5. Kashner T.M., Rush A.J. & Altshuler K.Z. (1999) Measuring cost of guideline-driven mental health care: the Texas medication algorithm project. The Journal of Mental Health Policy and Economics 2, 111-121.
6. Lieberman J.A. (2004) Metabolic changes associated with antipsychotic use. Primary Care Companion to the Journal of Clinical Psychiatry 6, 8-13.
7. National Association of State Mental Health Program Directors (1997) Algorithms and the medication treatment of people with serious mental illness. Available at National Association of Mental Health Program Directors web site: (accessed 15 March 2009).
8. Peritogiannis V., Tsouli S., Zafiris S., etal. (2006) Metabolic syndrome and the use of antipsychotics. Annals of General Psychiatry 5 (Suppl. 1), 5269. doi: 10.1186/1744-859X-5-S1-S269.
9. Sneed K.B. & Gonzalez E.C. (2003) Type 2 diabetes mellitus induced by an atypical antipsychotic. Journal of the American Board of Family Practice 16, 251-254.
10. The Commonwealth Fund (2006) Texas medication algorithm project. Available at The Commonwealth Fund web site: (accessed 15 March 2009).
11. Trivedi M.H., Rush A.J., Crismon M.L., etal. (2004) Clinical results for patients with major depressive disorder in the Texas medication algorithm project. Archives of General Psychiatry 61, 669-680.
12. Tschoner A., Engl J., Laimer M., etal. (2007) Metabolic side effects of antipsychotic medication. International Journal of Clinical Practice 61, 1356-1370.